Fresenius Medical Care AG Reports Improved Earnings
Fresenius Medical Care AG has released its financial results for 2024, showing improved earnings due to effective cost-cutting measures. The company’s revenue for 2024 was 19.34 billion euros, a 1% decrease from the previous year.
Key Financial Metrics
- Revenue: 19.34 billion euros (2024)
- Revenue change: -1% (compared to 2023)
- Adjusted EBIT: 1.81 billion euros (2024), an 18% increase
- Net income: 538 million euros (2024), an 8% increase
Stock Performance
The company’s stock has shown a recent increase of 2.4% to 45.26 euros. Deutsche Bank has a “hold” rating for the stock.
Dividend Payment
Fresenius Medical Care plans to pay a dividend of 1.44 euros per share, a 21% increase from the previous year.
2025 Profit Targets
The company has revised its profit targets for 2025. However, specific details regarding the revised targets are not provided in the latest release.